Details of the financing agreement signed by MedinCell and the European Investment Bank (EIB)
November 23, 2022
Previous PostAdditional US$ 4 million received for next development steps of MedinCell's 6-month active injectable bioresorbable subcutaneous contraceptive
Next PostFrance : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments
